Public expenditure

Lumen Technologies reports first quarter 2024 results

Retrieved on: 
Tuesday, April 30, 2024

DENVER, April 30, 2024 /PRNewswire/ -- Lumen Technologies, Inc. (NYSE: LUMN) reported results for the first quarter ended March 31, 2024.

Key Points: 
  • Revenue and Adjusted EBITDA excluding Special Items for the first quarter of 2023 includes $29 million and $18 million, respectively, from our divested CDN customer contracts.
  • (6) Excludes Special Items (net of the income tax effect thereof) which negatively impacted this metric by (i) $(98) million for the first quarter of 2024 and (ii) $(414) million for the first quarter of 2023.
  • (9) Excludes Special Items in the amounts of (i) $170 million for the first quarter of 2024 and (ii) $114 million for the first quarter of 2023.
  • (11) Excludes cash paid (received) for Special Items in the amounts of (i) $129 million for the first quarter of 2024 and (ii) $(30) million for the first quarter of 2023.

Generative AI Surge Triggers Nationwide Rush for New Data Center Infrastructure

Retrieved on: 
Monday, April 29, 2024

VANCOUVER, British Columbia, April 29, 2024 /PRNewswire/ -- USA News Group News Commentary – Demand for new AI Data Centers which are powering the rise of such popular AI platforms as OpenAI's ChatGPT is being grossly underestimated according to analysts at this year's Bloomberg Intelligence summit. The ongoing generative AI boom is kicking off a rush for new data centers, and the providers of the infrastructure behind them. With this boom comes many challenges including power supplies and the price of necessary hardware. For 9 of the top 10 US electric utilities, data centers have been the main source of customer growth, according to analysis made by Reuters. The booming Global Data Center Market is expected to hit US$792.3 billion by 2032, according to Astute Analytica, while analysts at Christian & Timbers have identified what they believe will be a 27% increase in AI data center talent demand in 2024 over 2023. Behind the scenes are several developers advancing the data center surge, who over the last week updated the market with recent developments, including: Avant Technologies Inc. (OTC: AVAI), Alphabet Inc. (NASDAQ: GOOG) (NASDAQ: GOOGL) (NEO: GOOG), Meta Platforms, Inc. (NASDAQ: META) (NEO: META), Pegasystems Inc. (NASDAQ: PEGA), and Advanced Micro Devices, Inc. (NASDAQ: AMD).

Key Points: 
  • The ongoing generative AI boom is kicking off a rush for new data centers , and the providers of the infrastructure behind them.
  • Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers
    Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an artificial intelligence technology (AI) company specializing in the development of advanced AI and data center infrastructure solutions, announced today its plans to implement a Zero Trust Architecture (ZTA) framework powered by AI within its data center operations.
  • "This combined approach ensures the highest level of security for our customers' data while optimizing data center operations for efficiency and cost-effectiveness.
  • Such advantages are vital for businesses aiming to upgrade their data center infrastructure and enhance computational capacity while actively striving to meet sustainability objectives.

Generative AI Surge Triggers Nationwide Rush for New Data Center Infrastructure

Retrieved on: 
Monday, April 29, 2024

VANCOUVER, British Columbia, April 29, 2024 /PRNewswire/ -- USA News Group News Commentary – Demand for new AI Data Centers which are powering the rise of such popular AI platforms as OpenAI's ChatGPT is being grossly underestimated according to analysts at this year's Bloomberg Intelligence summit. The ongoing generative AI boom is kicking off a rush for new data centers, and the providers of the infrastructure behind them. With this boom comes many challenges including power supplies and the price of necessary hardware. For 9 of the top 10 US electric utilities, data centers have been the main source of customer growth, according to analysis made by Reuters. The booming Global Data Center Market is expected to hit US$792.3 billion by 2032, according to Astute Analytica, while analysts at Christian & Timbers have identified what they believe will be a 27% increase in AI data center talent demand in 2024 over 2023. Behind the scenes are several developers advancing the data center surge, who over the last week updated the market with recent developments, including: Avant Technologies Inc. (OTC: AVAI), Alphabet Inc. (NASDAQ: GOOG) (NASDAQ: GOOGL) (NEO: GOOG), Meta Platforms, Inc. (NASDAQ: META) (NEO: META), Pegasystems Inc. (NASDAQ: PEGA), and Advanced Micro Devices, Inc. (NASDAQ: AMD).

Key Points: 
  • The ongoing generative AI boom is kicking off a rush for new data centers , and the providers of the infrastructure behind them.
  • Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers
    Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an artificial intelligence technology (AI) company specializing in the development of advanced AI and data center infrastructure solutions, announced today its plans to implement a Zero Trust Architecture (ZTA) framework powered by AI within its data center operations.
  • "This combined approach ensures the highest level of security for our customers' data while optimizing data center operations for efficiency and cost-effectiveness.
  • Such advantages are vital for businesses aiming to upgrade their data center infrastructure and enhance computational capacity while actively striving to meet sustainability objectives.

Daqo New Energy Announces Unaudited First Quarter 2024 Results

Retrieved on: 
Monday, April 29, 2024

(2)  Daqo New Energy provides EBITDA, EBITDA margins, adjusted net income attributable to Daqo New Energy Corp. shareholders and adjusted earnings per basic ADS on a non-GAAP basis to provide supplemental information regarding its financial performance.

Key Points: 
  • (2)  Daqo New Energy provides EBITDA, EBITDA margins, adjusted net income attributable to Daqo New Energy Corp. shareholders and adjusted earnings per basic ADS on a non-GAAP basis to provide supplemental information regarding its financial performance.
  • Total production volume for the quarter was 62,278 MT, which was above our expectations and represented an increase of 1,264 MT compared to the previous quarter.
  • Gross margin was 17.4%, compared to 18.3% in the fourth quarter of 2023 and 71.4% in the first quarter of 2023.
  • Operating margin was 7.3%, compared to 17.5% in the fourth quarter of 2023 and 65.3% in the first quarter of 2023.

EQS-News: BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates

Retrieved on: 
Friday, May 3, 2024

BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates

Key Points: 
  • BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates
    The issuer is solely responsible for the content of this announcement.
  • Media release as at April 26, 2024
    Portfolio of BB Biotech AG as at March 31, 2024
    BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates
    Investor sentiment in the biotech space continues to be shaped by the general interest rate environment.
  • Net profit for the first quarter of 2024 amounted to CHF 260 mn (net loss of CHF 254 mn in prior-year quarter).
  • While activity in the secondary market has already picked up, there have been few biotech IPOs so far this year.

EQS-News: Sartorius: First quarter results in line with expectations; recurring business with significant order growth; demand from China remains weak; outlook for full year confirmed

Retrieved on: 
Friday, May 3, 2024

Sartorius: First quarter results in line with expectations; recurring business with significant order growth; demand from China remains weak; outlook for full year confirmed (news with additional features)

Key Points: 
  • Sartorius: First quarter results in line with expectations; recurring business with significant order growth; demand from China remains weak; outlook for full year confirmed (news with additional features)
    The issuer is solely responsible for the content of this announcement.
  • The EBITDA margin continues to be at a robust level, and we anticipate further effects from our efficiency programs in the coming months."
  • In the Americas region, order intake grew at a double-digit rate of 26.1 percent, while sales revenue declined by 9.3 percent.
  • In Asia/Pacific, the continued market weakness in China led to a decline in both order intake (- 4.8 percent) and sales revenue (- 10.4 percent).

Denarius Metals Announces Positive Pre-Feasibility Study Results Supporting a Restart of Mining Operations at the Aguablanca Project in Extremadura, Spain

Retrieved on: 
Thursday, April 11, 2024

The Aguablanca Project is located in southwestern Spain, approximately a 45 minute drive north of Seville.

Key Points: 
  • The Aguablanca Project is located in southwestern Spain, approximately a 45 minute drive north of Seville.
  • Underground mining has been approved by the state mining authority and the Environmental Impact Study approved in 2017 is still in force.
  • The Aguablanca Project is currently in a position to quickly restart mining and processing operations.
  • The 5,000 tpd processing plant has been maintained in good condition over the years since it was last operated by Lundin Mining.

NFI announces first quarter 2024 results

Retrieved on: 
Thursday, May 2, 2024

WINNIPEG, Manitoba, May 02, 2024 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. ("NFI" or the "Company"), a leader in zero-emission electric mobility solutions, today announced its unaudited interim condensed consolidated financial results for the first quarter of 2024.

Key Points: 
  • Results noted herein are for the 13-week period ("2024 Q1”) and the 52-week period ("2024 Q1 LTM”) ended March 31, 2024.
  • NFI generated $10 million in cash flows from working capital in the first quarter of 2024, as higher vehicle deliveries lowered finished goods and work-in-process (“WIP”) inventory.
  • NFI anticipates that nearly all of the remaining legacy inflation-impacted contracts will be delivered during the second quarter of 2024.
  • NFI reiterates its previously provided financial guidance for Fiscal 2024 and targets for 2025 as disclosed on January 17, 2024.

Clarus Reports First Quarter 2024 Results

Retrieved on: 
Thursday, May 2, 2024

SALT LAKE CITY, May 02, 2024 (GLOBE NEWSWIRE) -- Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a global company focused on the outdoor enthusiast markets, reported financial results for the first quarter ended March 31, 2024.

Key Points: 
  • SALT LAKE CITY, May 02, 2024 (GLOBE NEWSWIRE) -- Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a global company focused on the outdoor enthusiast markets, reported financial results for the first quarter ended March 31, 2024.
  • Capital expenditures in the first quarter of 2024 were $1.9 million compared to $1.5 million in the prior year quarter.
  • Free cash flow for the first quarter of 2024 was an outflow of $18.3 million compared to positive free cash flow of $1.7 million in the prior year quarter.
  • The Company will hold a conference call today at 5:00 p.m. Eastern time to discuss its first quarter 2024 results.

Soleno Therapeutics Announces Proposed Public Offering of Common Stock

Retrieved on: 
Thursday, May 2, 2024

REDWOOD CITY, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Nasdaq:SLNO), ("Soleno" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today that it intends to offer and sell shares of its common stock in an underwritten public offering.

Key Points: 
  • REDWOOD CITY, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Nasdaq:SLNO), ("Soleno" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today that it intends to offer and sell shares of its common stock in an underwritten public offering.
  • In addition, Soleno intends to grant the underwriters a 30-day option to purchase an additional number of shares of common stock equal to 15% of the aggregate number of shares of its common stock sold in the public offering.
  • The public offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
  • The securities described above relating to the public offering are being offered by Soleno pursuant to a registration statement on Form S-3ASR (File No.